IPO Insights
Data-driven breakdowns of the IPOs that matter — financials, risk factors, and what it means for you. No fluff. No price targets. Just the numbers.
Manipal Hospitals
India's largest pan-India multispecialty hospital network by beds
Fresh Issue
₹8,000 Cr
+ OFS
FY25 Revenue
₹8,242 Cr
+33.6% YoY
EBITDA Margin
26.27%
Adjusted
Network
49 hospitals
12,631 beds
Manipal grew FY23-25 revenue at a 30.5% CAGR and has built scale through both new capacity and acquisitions. Final valuation remains the key question.
NSE
The world's largest derivatives exchange goes public
Revenue FY26
₹16,601 Cr
−3.2% YoY
PAT FY26
₹10,302 Cr
50.98% margin
EBITDA Margin
66.85%
World-class
Registered Investors
12.9 Cr
+14.4% YoY
NSE is the world's #1 equity derivatives exchange by contract volume. 100% OFS — no fresh issue. A tollgate on India's financial growth story.
Zepto
India's fastest-growing quick commerce platform
FY26 Revenue
₹22,624 Cr
+104% YoY
Fresh Issue
₹8,010 Cr
+ OFS
Dark Stores
1,139
66 cities
FY26 Net Loss
₹5,905 Cr
Improving
Revenue doubled to ₹22,624 Cr in FY26. EBITDA/order improved 42% YoY. But Blinkit is near-breakeven at -₹3/order vs Zepto's -₹79.
SpaceX
Rockets + Starlink + Grok AI + X — one company, one IPO
2025 Revenue
$18.67B
+39% YoY
Adj. EBITDA
$6.58B
35% margin
Starlink Subs
10.3M
164 countries
Grok+X MAUs
550M
117M AI users
SpaceX + xAI + X (Twitter) merged into one entity in early 2026. The S-1 includes $1.25B/month Anthropic compute deal. Indian investors can access via LRS.
More IPO analyses coming soon
PhonePe · Meesho · Pine Labs · and more
IPO Insights is for informational purposes only. Not investment advice. Always read the offer document and consult a SEBI-registered advisor before investing.